Differences between ipsilateral and contralateral early parenchymal enhancement kinetics predict response of breast cancer to neoadjuvant therapy
Rationale and Objectives To determine whether kinetics measured with ultrafast dynamic
contrast-enhanced magnetic resonance imaging in tumor and normal parenchyma pre-and …
contrast-enhanced magnetic resonance imaging in tumor and normal parenchyma pre-and …
[HTML][HTML] Association between background parenchymal enhancement and pathologic complete remission throughout the neoadjuvant chemotherapy in breast cancer …
C You, W Peng, W Zhi, M He, G Liu, L Xie, L Jiang… - Translational …, 2017 - Elsevier
PURPOSE: To retrospectively investigate the quantitative background parenchymal
enhancement (BPE) of the contralateral normal breast in patients with unilateral invasive …
enhancement (BPE) of the contralateral normal breast in patients with unilateral invasive …
[HTML][HTML] Association between background parenchymal enhancement and tumor response in patients with breast cancer receiving neoadjuvant chemotherapy
R Rella, E Bufi, P Belli, F Petta, T Serra… - Diagnostic and …, 2020 - Elsevier
Purpose To analyze the relationships between background parenchymal enhancement
(BPE) of the contralateral healthy breast and tumor response after neoadjuvant …
(BPE) of the contralateral healthy breast and tumor response after neoadjuvant …
[HTML][HTML] Background parenchymal enhancement of the contralateral normal breast: association with tumor response in breast cancer patients receiving neoadjuvant …
JH Chen, JY Hon, C Hsu, RS Mehta, PM Carpenter… - Translational …, 2015 - Elsevier
PURPOSE: This study investigated the association between background parenchymal
enhancement (BPE) and pathologic response to neoadjuvant chemotherapy (NAC) …
enhancement (BPE) and pathologic response to neoadjuvant chemotherapy (NAC) …
Ultrafast dynamic contrast-enhanced breast MRI: Association with pathologic complete response in neoadjuvant treatment of breast cancer
Objectives The purpose of this study was to investigate whether pretreatment kinetic features
from ultrafast DCE-MRI are associated with pathological complete response (pCR) in …
from ultrafast DCE-MRI are associated with pathological complete response (pCR) in …
Decreased background parenchymal enhancement of the contralateral breast after two cycles of neoadjuvant chemotherapy is associated with tumor response in …
C You, Y Gu, W Peng, J Li, X Shen, G Liu… - Acta …, 2018 - journals.sagepub.com
Background Several recent studies have focused on the association between background
parenchymal enhancement (BPE) and tumor response to neoadjuvant chemotherapy …
parenchymal enhancement (BPE) and tumor response to neoadjuvant chemotherapy …
[HTML][HTML] Background parenchymal enhancement: behavior during neoadjuvant chemotherapy for breast cancer and relationship with a pathological complete …
SRC Teixeira, HSA Camargo Júnior… - Radiologia Brasileira, 2020 - SciELO Brasil
Objective: To evaluate background parenchymal enhancement (BPE) and its characteristics,
as well as its behavior before and after neoadjuvant chemotherapy (NAC), in both breasts of …
as well as its behavior before and after neoadjuvant chemotherapy (NAC), in both breasts of …
Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results
CE Loo, HJ Teertstra, S Rodenhuis… - American Journal of …, 2008 - Am Roentgen Ray Soc
OBJECTIVE. The aim of this study was to establish changes in contrast-enhanced MRI of
breast cancer during neoadjuvant chemotherapy that are indicative of pathology outcome …
breast cancer during neoadjuvant chemotherapy that are indicative of pathology outcome …
Early prediction of pathologic complete response of breast cancer after neoadjuvant chemotherapy using longitudinal ultrafast dynamic contrast-enhanced MRI
Y Cao, X Wang, L Li, J Shi, X Zeng, Y Huang… - Diagnostic and …, 2023 - Elsevier
Purpose The purpose of this study was to evaluate the temporal trends of ultrafast dynamic
contrast-enhanced (DCE)-MRI during neoadjuvant chemotherapy (NAC) and to investigate …
contrast-enhanced (DCE)-MRI during neoadjuvant chemotherapy (NAC) and to investigate …
Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy
SP Li, A Makris, MJ Beresford, NJ Taylor, MLW Ah-See… - Radiology, 2011 - pubs.rsna.org
Purpose To investigate whether early changes in vascular parameters determined with
dynamic contrast material–enhanced magnetic resonance (MR) imaging after two cycles of …
dynamic contrast material–enhanced magnetic resonance (MR) imaging after two cycles of …
相关搜索
- breast cancer neoadjuvant chemotherapy
- tumor response neoadjuvant chemotherapy
- breast cancer tumor response
- neoadjuvant therapy enhancement kinetics
- breast cancer enhancement kinetics
- breast cancer early prediction
- breast mri neoadjuvant treatment
- breast cancer survival in patients
- early assessment neoadjuvant chemotherapy
- breast cancer neoadjuvant therapy
- tumor response contralateral breast
- breast cancer neoadjuvant treatment
- contralateral breast neoadjuvant chemotherapy
- early prediction neoadjuvant chemotherapy